Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mosnodenvir (JNJ-1802), a pan-serotype dengue antiviral agent, exhibits picomolar to low nanomolar in vitro activity with a high barrier to resistance and is safe and well-tolerated in murine models [1] [2]. It functions by blocking the NS3-NS4B interaction within the viral replication complex.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,520.00 | |
50 mg | 8-10 weeks | $ 1,980.00 | |
100 mg | 8-10 weeks | $ 2,500.00 |
Description | Mosnodenvir (JNJ-1802), a pan-serotype dengue antiviral agent, exhibits picomolar to low nanomolar in vitro activity with a high barrier to resistance and is safe and well-tolerated in murine models [1] [2]. It functions by blocking the NS3-NS4B interaction within the viral replication complex. |
Synonyms | JNJ-1802 |
Molecular Weight | 582.98 |
Formula | C26H22ClF3N2O6S |
CAS No. | 2890688-86-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mosnodenvir 2890688-86-3 Microbiology/Virology Virus Protease JNJ-1802 inhibitor inhibit